Premium
Effect of a dietary portfolio (nopal, chia, soy, oat and inulin) on serum lipoprotein profile in subjects with metabolic syndrome (1035.7)
Author(s) -
Aguilar Miriam,
Medina Isabel,
Guevara Martha,
Radyx Miriam,
Orozco Ximena,
Jimenez Edith,
Flores Adriana,
CastañoJameson Marisol,
Ayala Brenda,
Vazquez Natalia,
Tovar Armando,
Torres Nimbe
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.1035.7
Subject(s) - chylomicron , medicine , endocrinology , very low density lipoprotein , metabolic syndrome , triglyceride , lipoprotein , blood pressure , body mass index , dyslipidemia , chemistry , food science , obesity , cholesterol
Approximately one of each two Mexicans adults present metabolic syndrome. The initial treatment includes changes in lifestyle, such as the consumption of specific dietary portfolio (DP). The aim of this study was to assess the effect of this DP on subjects with metabolic syndrome on serum lipoprotein profile, anthropometric measurements, blood pressure and HbA1c. Thirty‐two patients after two and a half months of dietary treatment had a significant decrease in body weight (‐3.5%), BMI (‐6.2%), percentage of fat mass (‐2.7%), systolic and diastolic blood pressure (‐7%, ‐9.8%) and HBA1c (‐1.7%). There was a significant decrease in serum total triglycerides (‐20.9%), VLDL and chylomicron triglyceride (‐6.3%), IDL particles (‐20.7), LDL particles (‐6.3%) particularly the small LDL particles (‐13.6), whereas the large LDL particles increased (29.9%). In summary, the addition of functional food to the DP may reduce the cardiovascular risk by producing a less atherogenic lipoprotein profile. Grant Funding Source : Supported by Medix (to NT) and CONACYT grant 181685 (to MG)